VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX.V: RKV), (the “Company”) a biopharmaceutical company committed […]
First quarter revenue totaled $160.6 million, representing an increase of 16% year-over-year. Trailing four quarter average Net Dollar Retention Rate […]